IL107596A - History of crystalline carbapenems, pharmaceutical preparations containing them and methods for their preparation - Google Patents

History of crystalline carbapenems, pharmaceutical preparations containing them and methods for their preparation

Info

Publication number
IL107596A
IL107596A IL107596A IL10759693A IL107596A IL 107596 A IL107596 A IL 107596A IL 107596 A IL107596 A IL 107596A IL 10759693 A IL10759693 A IL 10759693A IL 107596 A IL107596 A IL 107596A
Authority
IL
Israel
Prior art keywords
compound
formula
doublet
crystals
crystalline form
Prior art date
Application number
IL107596A
Other languages
English (en)
Hebrew (he)
Other versions
IL107596A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL107596A0 publication Critical patent/IL107596A0/xx
Publication of IL107596A publication Critical patent/IL107596A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL107596A 1992-11-17 1993-11-12 History of crystalline carbapenems, pharmaceutical preparations containing them and methods for their preparation IL107596A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30688492 1992-11-17
JP17026793 1993-07-09

Publications (2)

Publication Number Publication Date
IL107596A0 IL107596A0 (en) 1994-02-27
IL107596A true IL107596A (en) 1998-02-08

Family

ID=26493307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107596A IL107596A (en) 1992-11-17 1993-11-12 History of crystalline carbapenems, pharmaceutical preparations containing them and methods for their preparation

Country Status (21)

Country Link
US (1) US5424306A (fr)
EP (1) EP0599512B1 (fr)
JP (1) JP2848552B2 (fr)
KR (1) KR100236845B1 (fr)
CN (1) CN1036714C (fr)
AT (1) ATE178066T1 (fr)
AU (1) AU677235B2 (fr)
CA (1) CA2103223C (fr)
CZ (1) CZ280507B6 (fr)
DE (1) DE69324106T2 (fr)
DK (1) DK0599512T3 (fr)
ES (1) ES2131560T3 (fr)
FI (1) FI103576B1 (fr)
GR (1) GR3029975T3 (fr)
HK (1) HK1011977A1 (fr)
HU (1) HU219582B (fr)
IL (1) IL107596A (fr)
NO (1) NO304431B1 (fr)
NZ (1) NZ250201A (fr)
PH (1) PH30464A (fr)
TW (1) TW360657B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711128C (en) * 1996-05-09 2002-11-07 Sankyo Company Limited Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
TWI250160B (en) 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
WO2004035539A1 (fr) * 2002-10-18 2004-04-29 Meiji Seika Kaisha, Ltd. Procede destine a la fabrication de carbapenem et intermediaire utilise dans sa fabrication
JP2008501657A (ja) * 2004-06-02 2008-01-24 サンド・アクチエンゲゼルシヤフト 結晶形態のメロペネム中間体
JP2009143808A (ja) * 2006-03-28 2009-07-02 Kaneka Corp メロペネム中間体の単離方法
SG185318A1 (en) 2007-01-12 2012-11-29 Novartis Ag Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
NO168304C (no) * 1988-04-01 1992-02-05 Sankyo Co Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-(heterocyklyltio)karbapenemderivater
JPH0745499B2 (ja) * 1988-05-10 1995-05-17 三共株式会社 １―メチルカルバペネム誘導体
EP0462521A1 (fr) * 1990-06-19 1991-12-27 Takeda Chemical Industries, Ltd. Pénème cristallin, sa préparation et son utilisation

Also Published As

Publication number Publication date
AU677235B2 (en) 1997-04-17
FI935063A0 (fi) 1993-11-16
JP2848552B2 (ja) 1999-01-20
US5424306A (en) 1995-06-13
FI935063A (fi) 1994-05-18
HUT66001A (en) 1994-08-29
TW360657B (en) 1999-06-11
EP0599512B1 (fr) 1999-03-24
KR100236845B1 (ko) 2000-02-01
CN1093366A (zh) 1994-10-12
HU219582B (hu) 2001-05-28
CZ280507B6 (cs) 1996-02-14
EP0599512A1 (fr) 1994-06-01
DE69324106D1 (de) 1999-04-29
JPH07165759A (ja) 1995-06-27
GR3029975T3 (en) 1999-07-30
KR940011463A (ko) 1994-06-21
NO304431B1 (no) 1998-12-14
CA2103223A1 (fr) 1994-05-18
ATE178066T1 (de) 1999-04-15
ES2131560T3 (es) 1999-08-01
NZ250201A (en) 1995-04-27
CN1036714C (zh) 1997-12-17
NO934140D0 (no) 1993-11-16
FI103576B (fi) 1999-07-30
CA2103223C (fr) 2002-09-24
DE69324106T2 (de) 1999-12-09
CZ245493A3 (en) 1995-08-16
FI103576B1 (fi) 1999-07-30
AU5063193A (en) 1994-06-02
PH30464A (en) 1997-05-28
DK0599512T3 (da) 1999-10-11
HK1011977A1 (en) 1999-07-23
NO934140L (no) 1994-05-18
IL107596A0 (en) 1994-02-27

Similar Documents

Publication Publication Date Title
AU2002348986B2 (en) Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs
DE2837264A1 (de) 7 beta -arylmalonamido-7 alpha -methoxy-3-thiadiazolylthio-1-oxadethiacephalosporine, ihre ester und salze, sowie verfahren zu deren herstellung
US5424306A (en) Crystalline carbapenem derivative
JPH0340030B2 (fr)
EP3471724A1 (fr) Compositions anti-bactériennes
KR100472842B1 (ko) 피롤리딜티오카르바페넴 유도체의 신형결정
DE3019244C2 (fr)
EP0329008B1 (fr) Dérivés de céphalosporine et procédé pour leur préparation
US4123547A (en) Thienamycin sulfoxide and sulphone
EP0301394B1 (fr) Acides oxapénèm-3-carboxyliques stables
US4123539A (en) 6-Ethylpenicillanic acid
JPS60233077A (ja) １‐テヘロ‐６‐〔１‐ヒドロキシエチル〕‐２‐ｓｒ↑８‐１‐カルバデチアペン‐２‐エム‐３‐カルボン酸
JPS60233078A (ja) ６‐〔１‐ヒドロキシエチル〕‐２‐ｓｒ↑８‐１‐メチル‐１‐カルバデチアペン‐２‐エム‐３‐カルボン酸
RU2090567C1 (ru) Кристаллический пивалоилоксиметил (ir, 5s, 6s)-[(4r)-2-оксо-4-пирролидинилтио]-6-[(ir)-1-гидроксиэтил]-1-метил-1-карбапен-2-ем-3-карбоксилат и способ его получения
CH640236A5 (en) 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2 -carboxylic acid and process for its preparation
EP0362622B1 (fr) Utilisation d'acides oxapenem-3-carboxyliques stables pour l'obtention d'un médicament destiné à l'inhibition de beta-lactamase
DE69829720T2 (de) Antimikrobielle Zusammensetzungen welche Vinylpyrrolidinon-Cephalosporin-Derivate und ein Carbapenemantibiotikum oder ein beta-lactamaseinhibitor enthaten
DE69909098T2 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
EP0548790B1 (fr) Acides (1'S)-hydroxyalkyloxapenem-3-carboxyliques et leur utilisation comme inhibiteurs de la bêta-lactamase
DE2819453C2 (fr)
US6242437B1 (en) Cephem derivatives
WO1995014692A1 (fr) Derives de carbapenem et leurs procedes de preparation
CA1202617A (fr) Napsylate de bacampicilline
JPH04103584A (ja) １―メチルカルバペネム誘導体
JP2003183281A (ja) カルバペネム化合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees